## **Core Concept**
The question describes a patient with symptoms and laboratory findings suggestive of a lymphoproliferative disorder. The key findings include weakness, cervical lymphadenopathy, splenomegaly, abnormal blood counts, and specific immunophenotypic characteristics of the lymphoid cells in the bone marrow and peripheral blood. The diagnosis of lymphoproliferative disorders relies heavily on the immunophenotyping of the abnormal lymphocytes.

## **Why the Correct Answer is Right**
The patient's presentation and lab findings, particularly the bone marrow showing a nodular lymphoid infiltrate and the specific immunophenotypic profile of the lymphocytes (negative for CD19, CD5, CD20, CD23, CD79B, and FMC7), point towards a diagnosis of **Hairy Cell Leukemia (HCL)**. HCL is a rare, chronic leukemia characterized by the infiltration of the bone marrow, spleen, and liver by malignant B cells. These cells typically have a distinctive "hairy" appearance under the microscope due to their surface projections. The neoplastic cells in HCL are usually positive for CD103, CD22, and CD11c but negative for the markers listed in the question, making this diagnosis consistent with the provided information.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details on the options, we can infer based on common lymphoproliferative disorders that conditions like Chronic Lymphocytic Leukemia (CLL) or Non-Hodgkin Lymphoma (NHL) would not fit well due to their distinct immunophenotypic profiles. CLL, for example, typically expresses CD5 and CD23.
- **Option B:** Similarly, other B-cell lymphoproliferative disorders might not match the unique combination of clinical presentation and immunophenotypic markers provided.
- **Option D:** Given the specifics of the case, diagnoses like T-cell lymphoproliferative disorders can be ruled out due to the B-cell nature of the markers discussed.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl in this case is the importance of **CD103** in the diagnosis of Hairy Cell Leukemia. While not directly mentioned, the absence of typical B-cell markers (like CD19, CD20) and the presence of specific antigenic profiles can guide towards HCL. HCL is notably responsive to cladribine and pentostatin, making accurate diagnosis critical for treatment planning.

## **Correct Answer:** C.